4Henderson D C, Cagliem E, Gray C, et al. Clozapine, dia betes mellitus, weight gain. and lipid abnormalities: A five- year naturalistic study. Am J Psychiatry, 2000, 157: 975.
6Weyer C, Funah T, Tanaka S, et al. Hypoadiponecfinemia i- nobesity and type 2 diabetes: ch06e aasoeifion with insulin re- sistance and hyperinsulinemia [ J ]. 31in Endocrinol Metab, 2001, 86(5): 1930.
7Baptista T, Kin N M, Beaulieu S, et al. Obesity and related metabolic abnormalities during antipsychotic drug[J]. National Medical Journal, 2010, 01: 682.
8Boston P F, Dursun S M, Reveley M A. Cholesterol and men tal disorder[J]. BrJ Psychiatry, 1996, 169: 682.
7Wirshing D A,Spellberg B J,Erhart S M,et al.Novel anti2p sychotics and new onset diabetes[J].Biol Psychiat ry,1998,44:778.
8Allison D B,Mentore J L,Moonseong H,et al.Antip2schotic2induced weight gain;a comprehensive research syn2thesis[J].Am J Psychiat ry,1999,156:1686.
9Lean M E, Pajonk F G. Patients on atypical antipsychotic drugs: another high- risk group for type 2 diabetes[J]. Diabetes Care, 2003, 26(5): 1597.
10Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorprornazine[J].Arch Gen Psychiatry, 1988, 45 (9) : 789.
6Zhang Y, Li W, Yan T, et al. Early detection of lesions of dorsal artery of foot in patients with type 2 diabetes me|litus by high- frequency ultrasonography. J Huazhong Univ Sci Techno log Med Sci, 2011, 29(3):387-390.
7Ko YH, Na KS, Kim CE, et al. The effectiveness of cross-tapering switching to ziprasidone in patients with schizophrenla or schizoaffeetive disorder[J]. Psychiatry In- vestig, 2014, 11(4):459.
8Juven-Wetzler A, Fostick L, Cwikel-Hamzany S, et al. Treatment with ziprasidone for schizophrenia patients with OCD [J]. Eur Neuropsychopharmacol, 2014,24(9) : 1454.
9Harvey PD, Bowie CR. Ziprasidone: efficacy, tolera- bility, and emerging data on wide ranging effectiveness [J]. Expert Opin Pharmacother, 2005,6 (2) : 337.
10Carpenter WT, Buchanan RW. Lessons to take home from CATTE [J]. Psychiatr Serv, 2008,59 (1) : 523.
